Published in Nat Rev Gastroenterol Hepatol on June 01, 2009
Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma. Nat Rev Clin Oncol (2013) 1.77
Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol (2013) 1.15
Intermittent gastric outlet obstruction caused by a prolapsing antral gastric polyp. World J Gastrointest Oncol (2010) 1.06
Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol (2012) 1.06
Beyond the GIST: mesenchymal tumors of the stomach. Radiographics (2013) 1.05
Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol (2013) 0.96
Gastric polyps: a review of clinical, endoscopic, and histopathologic features and management decisions. Gastroenterol Hepatol (N Y) (2013) 0.95
Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci (2010) 0.92
Gastric polyps: Association with Helicobacter pylori status and the pathology of the surrounding mucosa, a cross sectional study. World J Gastrointest Endosc (2015) 0.85
A white opaque substance-positive gastric hyperplastic polyp with dysplasia. World J Gastroenterol (2013) 0.82
Clinical guidelines: Consensus for the management of patients with gastric polyps. Nat Rev Gastroenterol Hepatol (2010) 0.78
Diagnosis and management of gastric dysplasia. Korean J Intern Med (2016) 0.77
[Inflammatory fibroid polyp: from Vanek's "submucosal granuloma" to the concept of submucosal mesenchymal neoplasia]. Pathologe (2010) 0.77
Changes in the spectrum of gastric polyps in the Chinese population. World J Gastroenterol (2015) 0.77
Gastric hyperplastic polyp with focal cancer. Gastroenterol Rep (Oxf) (2014) 0.77
Is surveillance colonoscopy necessary for patients with sporadic gastric hyperplastic polyps? PLoS One (2015) 0.77
Gastric hyperplastic polyps causing upper gastrointestinal hemorrhage in a young adult. World J Clin Cases (2013) 0.76
Endoscopic resection is effective for the treatment of bleeding gastric hyperplastic polyps in patients with and without cirrhosis. Endosc Int Open (2016) 0.75
Gastric Hamartomatous Polyps-Review and Update. Clin Med Insights Gastroenterol (2016) 0.75
Focal Intramucosal Adenocarcinoma Occurring in Gastric Hyperplastic Polyps: Two Case Reports. Case Rep Gastrointest Med (2015) 0.75
Unusual Endoscopic Findings in Children: Esophageal and Gastric Polyps: Three Cases Report. Medicine (Baltimore) (2016) 0.75
Hyperplastic gastric polyposis complicated by a high-grade sarcomatoid malignancy. Can J Gastroenterol Hepatol (2014) 0.75
Gastroduodenal Intussusception, Intermittent Biliary Obstruction and Biochemical Pancreatitis due to a Gastric Hyperplastic Polyp. Case Rep Gastroenterol (2014) 0.75
A 57 year old woman with polypoid gastric mass. Middle East J Dig Dis (2014) 0.75
The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea. Medicine (Baltimore) (2017) 0.75
Current Management of Benign Epithelial Gastric Polyps. Curr Treat Options Gastroenterol (2017) 0.75
Gastric polyps diagnosed by double-contrast upper gastrointestinal barium X-ray radiography mostly arise from the Helicobacter pylori-negative stomach with low risk of gastric cancer in Japan. Gastric Cancer (2016) 0.75
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24
Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch (2001) 10.93
Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40
The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci (2004) 4.13
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (2007) 3.40
ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc (2006) 3.12
Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol (2006) 3.02
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg (1996) 2.69
Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet (1988) 2.48
Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol (1997) 2.37
Diagnosis and treatment of gastric heterotopic pancreas. World J Surg (2006) 2.33
The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol (2009) 2.31
Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol (2001) 2.30
High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol (2006) 2.23
Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg (2005) 1.99
Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy (1994) 1.95
Heterotopic pancreas in the stomach: a case report and literature review. World J Gastroenterol (2007) 1.80
The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol (1998) 1.80
Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J Pathol (2008) 1.74
Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol (2007) 1.72
Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST). Br J Cancer (2007) 1.68
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology (1999) 1.66
Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol (2001) 1.61
Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol (2007) 1.61
Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol (1995) 1.59
Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol (2001) 1.58
p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol (2001) 1.58
Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy (1993) 1.58
Pharmacological management of Cronkhite-Canada syndrome. Expert Opin Pharmacother (2003) 1.50
Histopathological classification and malignant change in gastric polyps. J Clin Pathol (1985) 1.36
Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci (1996) 1.35
Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther (2005) 1.34
Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol (2008) 1.31
Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand A (1982) 1.29
Gastric polyps: classification and management. Arch Pathol Lab Med (2008) 1.29
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med (1998) 1.28
Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg (1996) 1.26
The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Eur J Gastroenterol Hepatol (1999) 1.19
Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. Ital J Gastroenterol Hepatol (1999) 1.15
Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol (2003) 1.14
Malignant transformation of gastric hyperplastic polyps: alteration of phenotypes, proliferative activity, and p53 expression. Hum Pathol (2002) 1.13
Gastric neuroendocrine carcinoma arising from heterotopic pancreatic tissue. J Clin Pathol (2004) 1.12
Management of gastrointestinal stromal tumors. Surg Clin North Am (2008) 1.10
Inflammatory fibroid polyps of the gastrointestinal tract: evidence for a dendritic cell origin. Am J Surg Pathol (2004) 1.09
Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. Ital J Gastroenterol (1996) 1.08
Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol (1998) 1.07
Symptomatic pyloric pancreatic heterotopia: report of three cases and review of the literature. Med Sci Monit (2006) 1.06
Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol (2004) 1.04
Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch (2005) 1.02
Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. J Clin Pathol (1985) 1.01
Inflammatory fibroid polyp or Vanek's tumour. Dig Surg (2007) 1.01
Microsatellite instability in hyperplastic and adenomatous polyps of the stomach. Cancer (1999) 1.00
Gastrointestinal manifestations of Cowden's disease. Report of four cases. J Clin Gastroenterol (1994) 0.99
Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg (2001) 0.99
Multiple and recurrent inflammatory fibroid polyps in a Devon family ('Devon polyposis syndrome'): an update. Gut (1992) 0.98
Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol (2001) 0.98
Differential diagnosis of reactive gastropathy. Semin Diagn Pathol (2005) 0.98
Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol (2002) 0.97
CD34 expression by inflammatory fibroid polyps of the stomach. Mod Pathol (1997) 0.97
Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Scand J Gastroenterol (2008) 0.96
Gastric preneoplastic lesions and epithelial dysplasia. Gastroenterol Clin North Am (2007) 0.94
Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy (1995) 0.93
Pyloric obstruction caused by prolapse of a hyperplastic gastric polyp. Hepatogastroenterology (2002) 0.92
Juvenile polyposis of the stomach: clinicopathological features and its malignant potential. J Clin Pathol (1997) 0.91
p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol (1993) 0.90
Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol (2002) 0.87
Gastric carcinoids. The Yale Experience. Arch Surg (1995) 0.87
Cronkite-Canada syndrome: gastrointestinal pathophysiology and morphology. Gastroenterology (1972) 0.86
Dyslipidemia and H pylori in gastric xanthomatosis. World J Gastroenterol (2007) 0.86
Preventive measures in Peutz-Jeghers syndrome. Fam Cancer (2001) 0.85
Gastric outlet obstruction due to giant hyperplastic gastric polyps. J Formos Med Assoc (2005) 0.84
The classification and significance of gastric polyps. Monogr Pathol (1977) 0.83
Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus. Am J Gastroenterol (2000) 0.82
Gastric xanthelasma in hyperplastic gastric polyposis. Arch Pathol Lab Med (1989) 0.82
[Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole]. Korean J Gastroenterol (2008) 0.80
Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol (2007) 0.78
Fundic gland polyps: a not so innocuous entity worth a careful evaluation. Am J Gastroenterol (1998) 0.76
Giant inflammatory fibroid polyp of stomach causing massive upper gastrointestinal bleeding. Indian J Gastroenterol (1991) 0.76
Fundic gland polyps and PPI: the Mozart effect of gastrointestinal pathology? Pol J Pathol (2006) 0.76
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature (2003) 10.33
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell (2009) 7.39
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev (2006) 5.53
Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res (2006) 4.83
Cystic neoplasms of the pancreas. N Engl J Med (2004) 3.89
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Simplified staging for hepatocellular carcinoma. J Clin Oncol (2002) 3.48
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol (2011) 3.27
Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology (2002) 3.27
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell (2005) 3.15
The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14
Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol (2012) 2.99
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology (2007) 2.96
Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc (2008) 2.94
Gastroesophageal reflux among different racial groups in the United States. Gastroenterology (2004) 2.87
Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg (2012) 2.85
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med (2006) 2.71
Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver. N Engl J Med (2005) 2.67
Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut (2011) 2.59
Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol (2013) 2.58
Helicobacter pylori in North and South America before Columbus. FEBS Lett (2002) 2.57
A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology (2010) 2.53
Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc (2011) 2.51
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med (2006) 2.46
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg (2008) 2.45
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43
A report card to grade Helicobacter pylori therapy. Helicobacter (2007) 2.41
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology (2014) 2.40
Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med (2006) 2.36
Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol (2007) 2.36
Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery: a clinicopathologic study of five cases. Am J Surg Pathol (2003) 2.35
Autoimmune pancreatitis: imaging features. Radiology (2004) 2.34
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32
Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc (2006) 2.31
The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol (2009) 2.31
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg (2005) 2.27
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol (2010) 2.26
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg (2013) 2.26
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol (2009) 2.15
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med (2003) 2.09
Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology (2009) 2.05
Retrospective evaluation of elastic stain in the assessment of serosal invasion of pT3N0 colorectal cancers. Am J Surg Pathol (2013) 2.04
Gastric intestinal metaplasia with basal gland atypia: a morphological and biologic evaluation in a large Chinese cohort. Hum Pathol (2012) 2.04
Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc (2010) 2.04
Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter (2009) 2.02
Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol (2011) 1.98
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA (2008) 1.94
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol (2012) 1.89
New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol (2010) 1.80
Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med (2005) 1.80
Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79
Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology (2009) 1.78
Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76
Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand J Gastroenterol (2009) 1.75
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res (2006) 1.75
NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med (2002) 1.75
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter (2011) 1.73
Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol (2002) 1.72
EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc (2007) 1.70
Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer (2002) 1.69
Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc (2010) 1.68
Eosinophilic gastroenteritis associated with systemic lupus erythematosus. J Clin Gastroenterol (2004) 1.67
The Cables gene on chromosome 18Q regulates colon cancer progression in vivo. Cancer Biol Ther (2005) 1.65
Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol (2002) 1.65
Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med (2004) 1.65
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer Res (2009) 1.64
Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol (2006) 1.62
Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol (2010) 1.61
Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology (2004) 1.59
Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology (2002) 1.58
The diagnostic value of the duodenal biopsy: a clinico-pathologic analysis of 28,000 patients. Dig Liver Dis (2009) 1.58
Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol (2005) 1.57
Endoscopic demonstration of transient small bowel intussusception in a patient with adult celiac disease. Gastrointest Endosc (2003) 1.55
Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc (2005) 1.55
Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery (2005) 1.54
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol (2005) 1.53
Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol (2007) 1.53
Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 1.52
Endoscopic mucosal resection using a cap-fitted endoscope improves tissue resection and pathology interpretation: an animal study. Gastric Cancer (2006) 1.52